Tofigh Darou Research and Engineering Company

What Tofigh Darou Research and Engineering Company does

Tofigh Darou Research and Engineering Company (توفیق دارو), founded in 1999 and headquartered in Tehran, Iran, is a knowledge-based pharmaceutical research and engineering firm that operates as the dedicated R&D center of TIPICO (Iran Pharmaceutical Equipment Company), Iran's largest pharmaceutical holding. The company designs, develops, and produces Active Pharmaceutical Ingredients (APIs) across eight therapeutic categories — anti-cancer, cardiovascular, neurological, anti-diabetic, antiviral, immune system, peptide-based, and narcotic/analgesic products — along with finished dosage forms. Approximately 60 pharmaceutical innovations have been developed in-house over its ~26-year operating history, supported by capabilities in API synthesis, peptide chemistry (including complex molecules such as Semaglutide, Octreotide, and Triptorelin), molecular biology, and drug discovery. The firm also operates Todabin (تودابین), a wholly-owned adjacent subsidiary producing next-generation bioactive bone grafts for orthopedic and maxillofacial applications.

The company's business model combines B2B API and finished-dose supply to domestic Iranian pharmaceutical manufacturers with export of selected APIs and technical know-how to international markets. Revenue is generated through three principal streams: (1) API manufacturing and sale, (2) licensing and export of proprietary technical knowledge and products, and (3) contract research, industrial site construction, and manufacturing setup services. Pricing is not publicly disclosed. The go-to-market motion is enterprise field sales, with visibility at industry exhibitions (Iran Pharma, Pharmex, Iran Health), direct engagement with international delegations, and participation in public tenders. The company employs 51–100 staff and is supervised by Iran's Ministry of Cooperatives, Labor and Social Welfare.

Tofigh Darou positions itself as Iran's largest pharmaceutical R&D center and a strategic national asset for reducing import dependency on APIs and high-technology medicines. Its customer base is institutional — primarily domestic pharmaceutical manufacturers and selected international buyers — while ultimate end-users are healthcare providers and patients across Iran and select export markets.

Name

Tofigh Darou Research and Engineering Company

Legal name

Tofigh Darou Research and Engineering Company (شرکت تحقیقاتی مهندسی توفیق دارو)

Website

https://todaco.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

51–100 employees

Short description

Tofigh Darou Research and Engineering Company is Iran's largest pharmaceutical R&D center and a subsidiary of TIPICO holding, developing and manufacturing Active Pharmaceutical Ingredients across eight therapeutic categories plus peptide and bone graft products for domestic and international B2B pharmaceutical buyers.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industry

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE)

Keywords

• Active pharmaceutical ingredients
• Pharmaceutical manufacturing
• API synthesis services
• Peptide-based drugs
• Generic pharmaceuticals

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure

Revenue model

1. API Manufacturing and Sale: Design, development, and production of active pharmaceutical ingredients (APIs) across multiple therapeutic categories for domestic pharmaceutical companies and export markets. This is the primary revenue stream.
2. Export of Technical Know-How and Products: Export of proprietary technical knowledge and selected pharmaceutical products to international markets, generating foreign revenue and positioning Iran in the global pharmaceutical value chain.
3. Contract Research and Project Execution: R&D project execution, industrial site construction, and manufacturing setup services for pharmaceutical production facilities, conducted as a research engineering company under TIPICO.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Tofigh Darou manufactures and supplies Active Pharmaceutical Ingredients (APIs) and finished dosage pharmaceutical products across multiple therapeutic categories including oncology, cardiovascular, anti-diabetic, neurological, antiviral, immune system, peptide-based, and narcotic therapies. The company also develops specialty products such as bioactive bone grafts and offers contract research services alongside export of proprietary technical know-how to international pharmaceutical clients.

Product overview

Tofigh Darou Research and Engineering Company is Iran's largest pharmaceutical research center and a knowledge-based enterprise. The company operates as a comprehensive pharmaceutical manufacturer producing Active Pharmaceutical Ingredients (APIs) and finished pharmaceutical products. The portfolio spans multiple therapeutic categories: Anti-Cancer products (8 oncology medications), Cardiovascular products (9 products including Apixaban, Rivaroxaban), Anti-Diabetic products (5 medications), Neurological products (4 medications), Immune System products (8 medications), Antiviral products, Peptide-based medications (7 products), Narcotic/analgesic products (4 medications), and Miscellaneous products (6 items). Additionally, the company offers Todabin (تودابن), a next-generation bioactive bone graft medical device for orthopedic and maxillofacial applications. The company serves as Tipico Holding's research and development center and exports both technical knowledge and products to international markets. Approximately 60 pharmaceutical innovations have been developed by the company's elite researchers.

Differentiator

Problem solved

Functional benefit

Brands

• Todabin (تودابن): Medical equipment brand - next generation bioactive bone grafts for bone reconstruction in maxillofacial surgery and orthopedics

Products and services

• Anti-Cancer Pharmaceutical Products A line of Active Pharmaceutical Ingredients and finished oncology formulations developed for pharmaceutical manufacturers and healthcare providers.
• Cardiovascular Pharmaceutical Products Cardiovascular Active Pharmaceutical Ingredients and finished dosage forms such as Apixaban and similar molecules supplied to pharmaceutical manufacturers.
• Anti-Diabetic Pharmaceutical Products Active Pharmaceutical Ingredients and finished dosage forms targeting diabetes management, supplied to pharmaceutical manufacturers.
• Neurological Pharmaceutical Products Neurological Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
• Antiviral Pharmaceutical Products Antiviral Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
• Immune System Pharmaceutical Products Immunology-related Active Pharmaceutical Ingredients and finished dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
• Peptide-Based Pharmaceutical Products Peptide Active Pharmaceutical Ingredients and finished peptide-based dosage forms supplied to pharmaceutical manufacturers and healthcare providers.
• Narcotic Pharmaceutical Products Controlled narcotic Active Pharmaceutical Ingredients and finished dosage forms supplied to licensed pharmaceutical manufacturers and healthcare providers.
• Miscellaneous Pharmaceutical Products Miscellaneous Active Pharmaceutical Ingredients and finished dosage forms not classified under the company's primary therapeutic categories.
• Todabin Bioactive Bone Graft Specialty bioactive bone graft product for orthopedic and dental applications, supplied to medical device distributors and healthcare providers.
• Contract Research and Project Execution Services Contract pharmaceutical research, process development, and project execution services provided to pharmaceutical manufacturers seeking R&D partnership.
• Export of Technical Know-How and Products International licensing and technology transfer offering covering proprietary pharmaceutical manufacturing know-how and finished products supplied to overseas pharmaceutical clients.

Quantifiable outcome

• Approximately 60 pharmaceutical innovations developed and delivered to patients in Iran and globally
• +1 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• TIPICO (Tajhizat Pezeshki Iran — Iran Pharmaceutical Equipment Company)coreStrategic or Co-development PartnerTofigh Darou serves as the R&D center of TIPICO, Iran's largest pharmaceutical holding company. As an integral part of TIPICO, the company contributes to the holding's broader mission of pharmaceutical development, manufacturing, and export. TIPICO oversees the company's strategic direction within Iran's largest pharmaceutical ecosystem.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics and APIs regionally. Comparable as a regional Middle East branded-pharma peer operating in adjacent GCC markets under similar regulatory dynamics.
• SPIMACO Addwaeih: Saudi Arabia's largest pharmaceutical manufacturer, producing APIs and finished dosage forms across broad therapeutic categories. Comparable as a regional Middle East peer with diversified API + branded pharma operations similar to Tofigh Darou.

Others

• Dr. Reddy's Laboratories: India-based global pharmaceutical company with API manufacturing and finished formulations across multiple therapeutic areas including oncology and cardiovascular. Comparable as a broad incumbent with similar multi-category API + branded strategy.

Direct peers

• Divis Laboratories: India-based pure-play API manufacturer specializing in complex, high-value APIs including peptides and cardiovascular compounds. Closely comparable to Tofigh Darou's API-centric, multi-therapeutic, peptide-capable business model.
• Sobhan Oncology: Iranian specialty pharmaceutical manufacturer focused on oncology products. Directly comparable given Tofigh Darou's anti-cancer API category (Elapirib, Bortezomib, Pomalidomide, Thalidomide, Temozolomide) overlaps with Sobhan's oncology focus.
• Barakat Pharmaceutical: Iranian pharmaceutical holding with API and finished-dose capabilities across multiple therapeutic categories. Directly comparable as a domestic Iranian API/formulation competitor serving the same national self-sufficiency mandate.
• Darou Pakhsh Pharma: Iran's largest pharmaceutical manufacturer by sales; produces a broad portfolio of finished drugs across multiple therapeutic categories in Iran. Directly comparable as a domestic Iranian pharma producing across overlapping therapeutic areas and serving the same formulator/provider customers.

Broad incumbents

• Hikma Pharmaceuticals: Jordan-headquartered multinational specialty pharma with strong Middle East footprint in generics, injectables, and branded products. Comparable as a regional incumbent operating across overlapping therapeutic categories and serving MENA markets.
• Aurobindo Pharma: India-based global API and generics manufacturer with deep expertise in small-molecule API synthesis across cardiovascular, anti-diabetic, oncology, and CNS categories. Comparable as a large-scale multi-therapeutic API manufacturer.
• Cipla: India-headquartered global pharmaceutical manufacturer with broad API and finished-dose operations including respiratory, cardiovascular, and oncology. Comparable as a multi-therapeutic branded pharma + API incumbent in emerging markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tofigh-daru

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tofigh Darou Research and Engineering Company